MIRM Stock Summary and Trading Ideas (Mirum Pharmaceuticals | NASDAQ:MIRM)

Mirum Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing therapies for rare and orphan diseases. Its main product, Livmarli (maralixibat), is an orally administered IBAT inhibitor approved to treat cholestatic pruritus in patients with Alagille syndrome. The company is also developing treatments such as maralixibat for PFIC and ALGS, and volixibat for adult cholestatic liver diseases. Mirum currently has three approved medicines: Livmarli, Cholbam, and Ctexli.

What symbol and exchange does Mirum Pharmaceuticals shares trade?

Mirum Pharmaceuticals trades on the NASDAQ stock market under the symbol MIRM.

What is Mirum Pharmaceuticals stock price doing today?

As of June 17, 2026, MIRM stock price climbed to $102.04 with 949,476 million shares trading.

What is Mirum Pharmaceuticals's Beta?

MIRM has a beta of 1.11, meaning it tends to be more sensitive to market movements. MIRM has a correlation of 0.10 to the broad based SPY ETF.

How much is Mirum Pharmaceuticals worth?

MIRM has a market cap of $6.22 billion. This is considered a Mid Cap stock.

How much money does Mirum Pharmaceuticals make?

Last quarter Mirum Pharmaceuticals reported $160 million in Revenue and -$.50 earnings per share. This beat revenue expectation by $12 million and missed earnings estimates by -$.14.

What is the highest and lowest price Mirum Pharmaceuticals traded in the last 3 year period?

In the last 3 years, MIRM traded as high as $114.99 and as low as $23.14.

What are the top ETFs holding Mirum Pharmaceuticals?

The top ETF exchange traded funds that MIRM belongs to (by Net Assets): VTI, XBI, IWM, VB, VXF.

Is Mirum Pharmaceuticals (MIRM) a good investment?

MIRM has outperformed the market in the last year with a price return of +102.4% while the SPY ETF gained +24.2%. However, in the short term, MIRM had mixed performance relative to the market. It has underperformed in the last 3 months, returning +10.1% vs +11.0% return in SPY. But in the last 2 weeks, MIRM shares have fared better than the market returning +10.7% compared to SPY -2.5%.

What are the support and resistance levels for Mirum Pharmaceuticals (MIRM)?

MIRM support price is $98.46 and resistance is $104.64 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MIRM shares will trade within this expected range on the day.